why choose us

First received: February 09, 2023

Clinical Trial: Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Ototoxicity, Drug-Induced

Study Type: INTERVENTIONAL


Official Title: Cisplatin and Sodium Thiosulfate Otoprotection With or Without SAHA/Vorinostat Histone Deacetylase Inhibition for Relapsed/Refractory Hepatoblastoma and Other Embryonal Tumors

Brief Summary: This study will attempt to demonstrate the efficacy of Sodium Thiosulfate (STS) in preventing hearing loss in patients re-treated with cisplatin-based therapy according to regimens Cisplatin and STS (regimen CS) and Cisplatin, STS and Vorinostat/SAHA (regimen CSS).

Read more